Cycloxaprid is a selective serotonin and dopamine reuptake inhibitor belonging to the imidazopyrazine class of antidepressants, primarily indicated for the treatment of major depressive disorder through… Read more
Cycloxaprid is a selective serotonin and dopamine reuptake inhibitor belonging to the imidazopyrazine class of antidepressants, primarily indicated for the treatment of major depressive disorder through the modulation of monoamine neurotransmitter levels within the central nervous system. Laboratories requiring high-precision analysis of this compound rely on a comprehensive suite of reference standards, including structurally verified impurities and metabolites, to ensure rigorous quality control and accurate impurity profiling. The inclusion of stable isotope labelled standards allows researchers to perform precise quantification in complex biological matrices, facilitating robust bioanalytical method development and validation. These pharmaceutical reference materials are essential for conducting reliable stability testing and monitoring degradation pathways, ensuring compliance with regulatory standards throughout the drug development lifecycle. By utilizing these precise analytical tools, chemists can effectively identify, quantify, and characterize Cycloxaprid and its related substances in diverse research and manufacturing applications.